Regeneron hit by 'safety signal' for COVID-19 cocktail as data board tells pharma to stop enrolling sicker patients Hospitals hit with ransomware attacks as FBI warns of escalating threat to healthcare AstraZeneca taps Lonza to produce COVID-19 antibody headed for phase 3 Scripps researchers find COVID-19 signals in daily activity data from Fitbits, smartwatches The doctor will Zoom you now: Pharma execs talk ins and outs of telehealth The list of the 20 highest paid specialties in 2020 as average physician pay dips: Doximity Teladoc finalizes blockbuster deal with Livongo in less than three months Novo's Rybelsus launch is on the up-and-up after taking pandemic hit: execs Deloitte: Medicare Advantage plans that don't embrace telehealth 'will get left behind' Trump administration pushes back compliance deadline for info blocking rule Biopharma roundup: CDC relies on states to establish vaccine sites Featured Story | By Ben Adams The saga of COVID-19 antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump and touted as a cure has been hit by safety worries as it continues to push for an FDA emergency authorization. read more |
| |
|---|
|
Top Stories By Heather Landi Federal agencies warn that cybercriminals are escalating their extortion attempts against the healthcare sector even as hospitals are facing a nationwide surge in COVID-19 cases. Several U.S. hospitals have already been targeted in ransomware attacks this week. Here are the key threat details you need to know. read more By Fraiser Kansteiner Lonza is plowing ahead in the COVID fight with production work on Moderna's mRNA-based vaccine and Humanigen's monoclonal antibody lenzilumab. Now, it's signed on to manufacture AstraZeneca's dual-antibody hopeful, AZD7442, too. read more By Conor Hale By casting a broad, digital net to pick up the signs of coronavirus outbreaks, researchers hope to build an early warning system that uses data from people’s wearable activity trackers. read more By Beth Snyder Bulik Telehealth is surging during the pandemic. And with estimates pegging telehealth growth at as much as 80% in 2020, it’s not an area pharma can afford to ignore. Ironwood Pharmaceuticals and Evofem Biosciences aren't. Top commercial executives from both companies discussed how they're using telehealth to engage with patients and ease their path to prescriptions at Digital Pharma Innovation Week. read more By Tina Reed Here's a look at which specialties are still seeing the most growth even as Doximity reports average compensation is essentially down due to inflation. read more By Heather Landi Telehealth giant Teladoc completed its massive $18.5 billion acquisition of Livongo, the company announced Friday. The deal was wrapped up quickly, in under three months, as the companies likely look to leverage the current financial tailwinds of the telehealth boom and investor interest in digital health spurred by the COVID-19 pandemic. read more By Eric Sagonowsky Novo Nordisk entered 2020 with big expectations around its oral diabetes med Rybelsus, and while the pandemic has slowed the launch some, other meds have carried the day and propelled the company to revenue growth. read more By Paige Minemyer COVID-19 has dramatically accelerated the adoption of digital health, and a new analysis from Deloitte finds that trend extends similarly to Medicare Advantage beneficiaries. read more By Heather Landi Providers are getting an additional five months to comply with new regulations aimed at improving data sharing. The Trump administration issued an interim final rule Thursday that extends the compliance deadlines for healthcare information blocking and interoperability regulations. read more By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner Regeneron may stop enrolling the sickest patients in one of its antibody trials due to safety concerns. Novo's Rybelsus is rebounding from a pandemic sales hit. Activity trackers could help detect COVID, Scripps research found. States lack funding for a national shot rollout. And Israel will kick off a human trial of its vaccine Sunday. read more |
